THYMALINUM
Producer: CIAO Biofarm Ukraine
Code of automatic telephone exchange: L03A X
Pharm group: a href="javascript:if(confirm(%27medicalmeds.eu/preparats_title.php?name=-1&mnn=-1&atc=30 \n\nThis file was not retrieved by Teleport Pro, because it is linked too far away from its Starting Address. If you increase the in-domain depth setting for the Starting Address, this file will be queued for retrieval. \n\nDo you want to open it from the server?%27))window.location=%27medicalmeds.eu/preparats_title.php?name=-1&mnn=-1&atc=30%27" tppabs="medicalmeds.eu/preparats_title.php?name=-1&mnn=-1&atc=30">Immunostimulators
Release form: Firm dosage forms. Lyophilisate for solution for injections.
General characteristics. Structure:
Active ingredient: 1 ampoule (1 bottle) of the soderzhitsukhy cleared ekstraktatimus (thymus) of cattle of 10 mg;
excipient: glycine.
Main physical and chemical properties: amorphous powder or porous mass of color, white or white with a yellowish shade.
Pharmacological properties:
Pharmacodynamics. Regulates quantity and a ratio of T - and V-lymphocytes and their subpopulations, stimulates reactions of cellular immunity, strengthens phagocytosis, stimulates processes of regeneration and a hemopoiesis in case of their oppression, and also improves the course of processes of cellular metabolism.
Pharmacokinetics. It was not studied.
Indications to use:
It is applied in complex treatment of the diseases which are followed by decrease in cellular immunity:
- acute and chronic pyoinflammatory diseases of bones and soft tissues;
- disturbance of regenerator processes (fractures of bones, burns, frostbites, trophic ulcers, beam necroses of fabrics, peptic ulcer of a stomach and duodenum);
- acute and persistent bacterial and viral infections, the multiple sclerosis obliterating atherosclerosis, a pseudorheumatism;
oppression of immunity and hemopoiesis after performing radiation therapy or chemotherapy, use of high doses of antibiotics.
Route of administration and doses:
Before use contents of an ampoule (bottle) are dissolved in 1-2 ml by 0,9%rastvor of sodium of chloride. The scheme of dosing of Thymalinum is defined by the clinical immunologist on the basis of clinical and laboratory inspection of the patient.
Enter intramusculary daily in the following doses: the adult - on 5-20 mg (30-100 mg on a course), детямв age till 1 year – on 1 mg; 1-3 years – on 1-2 mg; 4-6 years – on 2-3 mg; 7-14 years – on 3-5 mg within 3-10 days depending on expressiveness of disturbances of immunity. If necessary carry out a repeated course of treatment (in 1-6 months).
Features of use:
Treatment by Thymalinum should be carried out at regular control of immunological indicators. With care appoint to patients with IgE-dependent pathology. Thymalinum can exponentiate allergic reactions to other medicines at their simultaneous use.
Side effects:
Allergicheskiyereaktion are possible.
Interaction with other medicines:
Let's combine with biostimulators and the immunostimulating drugs, rifampicin, an isoniazid, glucocorticoid drugs. It is necessary to avoid simultaneous use of Thymalinum and T-activin, a timaktid, a timogen or a timoptin which have the similar mechanism of action.
Contraindications:
Hypersensitivity to drug components. Autoimunny diseases. Pregnancy, feeding period breast.
Overdose:
It was not observed.
Storage conditions:
To store in protected from light and the place, unavailable to children, at a temperature not vyshe25 °C.
Issue conditions:
According to the recipe
Packaging:
On 30 mg of drug in an ampoule (bottle). On 10 ampoules (bottles) in a pack.